39m agoThe FlyBEARISH 32Earnings
Why Is XENON PHARMACEUTICAL (XENE) Stock Down Today?
By the Top Tier Newswire AI Desk · reviewed against 17 wire stories
XENON PHARMACEUTICAL (XENE) is down -29.01% in the latest session. Our newswire has captured 17 stories on XENE across 7 sources in the last 36 hours, with AI sentiment reading bearish (avg 41/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
The written analysis for XENE publishes to the public page once it clears the 4-hour delay. The coverage, sentiment and session data below are already here.
XENE by the numbers
Last: $40.72Session: -29.01%7 sessions: -3.69%Coverage: 17 stories / 7 sourcesAI sentiment: 41/100 (bearish)
The headlines behind the move
42m agoMarketChameleonBULLISH 67Product/PR
Xenon files azetukalner NDA for focal seizures as psychiatry enrollment is temporarily paused September 18, 2026
Xenon said it submitted an FDA New Drug Application for azetukalner in focal seizures, citing positive results from the Phase 2b X-TOLE and Phase 3 X-TOLE2 trials and more than 1,500 patient-years of epilepsy safety exposure. The company also temporarily paused enrollment of new patients in ongoing psychiatry studies after reviewing neuropsychiatric adverse events, while noting X-NOVA2 enrollment in MDD is complete at approximately 360 patients with topline data expected in Q1 2027.
2h agoInvesting.com Analyst RatingsBULLISH 56Analyst
Stifel reiterates Buy on Xenon Pharmaceuticals stock after trial pause
Stifel reiterates Buy on Xenon Pharmaceuticals stock after trial pause
2h agoThe FlyBEARISH 34Analyst
Xenon Pharmaceuticals price target lowered to $70 from $81 at RBC Capital
2h agoInvesting.com Analyst RatingsBEARISH 34Analyst
Needham cuts Xenon Pharmaceuticals stock price target on trial pause
Needham cuts Xenon Pharmaceuticals stock price target on trial pause
2h agoThe FlyBEARISH 34Analyst
Xenon Pharmaceuticals price target lowered to $55 from $71 at Wedbush
3h agoCNBCNEUTRAL 50General
Stocks making the biggest moves premarket: Netflix, Nucor, Xenon Pharmaceuticals & more
These are the stocks posting the largest moves premarket.
3h agoBarron'sBEARISH 22Product/PR
Xenon Stock Faces Worst Day Since 2017 as Lead Drug Proves a Double-Edged Sword
3h agoInvesting.com Analyst RatingsNEUTRAL 47Analyst
H.C. Wainwright reiterates Xenon Pharmaceuticals stock rating on study pause
H.C. Wainwright reiterates Xenon Pharmaceuticals stock rating on study pause
3h agoBarron'sBEARISH 34General
S&P 500 Futures Rise in Premarket Trading; Xenon Pharmaceuticals, Icon PLC Lag
Frequently asked questions
Why is XENE stock down today?
XENON PHARMACEUTICAL (XENE) is down -29.01% in the latest session. Our newswire has captured 17 stories on XENE across 7 sources in the last 36 hours, with AI sentiment reading bearish (avg 41/100). The most recent driver: "Xenon Pharmaceuticals falls -29.8%" (The Fly).
Is XENE a buy right now?
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of XENE coverage reads 41/100 over 17 stories; treat it as a research signal and do your own diligence.
How fast does this page update?
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More moves explained today
- Why is MSTR up today (+11.07%)
- Why is ALMR up today (+11.03%)
- Why is SECZ up today (+10.53%)
- Why is COIN up today (+9.89%)
- Why is SBET up today (+9.69%)
- Why is EMAT down today (-9.33%)
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on XENE: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.